A top US lawyer recently spoke at a conference in Washington where he placed focus on four cases for the Supreme Court, two antitrust and two patent cases, as the most important business cases this term. The top advocate for the Supreme Court under the Obama administration, solicitor General Donald Verrilli, made his remarks at an event at Georgetown Law Center. Perhaps most notable is his comment that the Federal Trade Commission, in a way, “won” in the Supreme Court in the court’s unanimous decision in FTC vs. Phoebe Putney Health System; decided last February, the Court ruled that the local hospital authority was not immune to federal antitrust law. Verrilli also mentioned the current FTC vs. Actavis course, which will be argued on March 25 concerning pay-for-delay pharmaceutical deals.
Featured News
Meta Halts Commercial Terms Rollout After Publishers Raise Concerns in EU, UK
Oct 28, 2026 by
CPI
Nvidia’s $12.9 Billion Hugging Face Deal Draws Justice Department Questions
Oct 28, 2026 by
CPI
Rolls-Royce’s UltraFan Wins £2.5 Billion UK Framework Deal
Oct 28, 2026 by
CPI
Taiwan Blocks Grab’s $600 Million Foodpanda Deal, Citing Uber Ties
Oct 28, 2026 by
CPI
South Korea Expands Food Price-Fixing Probe to Four Major Instant Noodle Makers
Oct 28, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Exclusive Dealing
Oct 25, 2026 by
CPI
Exclusive Dealing Without Exclusivity: Screening Contracts, Loyalty Rebates, and the Limits of Antitrust Tests
Oct 25, 2026 by
David Martimort & Jérôme Pouyet
When Competition for Exclusivity Raises Prices: Rebates, Pricing Rules, and the Insulin Puzzle
Oct 25, 2026 by
Daniel P. O’Brien & Greg Shaffer
Why Leaving the Door Open Can Be (Much) Worse Than Closing It: Share-Based Requirements, Buyer-Specific Costs, and Foreclosure
Oct 25, 2026 by
Zhijun Chen & Greg Shaffer
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI